Coronary Artery Perforations: Glasgow Natural History Study of Covered Stent Coronary Interventions (GNOCCI) Study

Thomas J Ford, Carly Adamson, Andrew J Morrow, Paul Rocchiccioli, Damien Collison, Peter J McCartney, Aadil Shaukat, Mitchell Lindsay, Richard Good, Stuart Watkins, Hany Eteiba, Keith Robertson, Colin Berry, Keith G Oldroyd, Margaret McEntegart, Thomas J Ford, Carly Adamson, Andrew J Morrow, Paul Rocchiccioli, Damien Collison, Peter J McCartney, Aadil Shaukat, Mitchell Lindsay, Richard Good, Stuart Watkins, Hany Eteiba, Keith Robertson, Colin Berry, Keith G Oldroyd, Margaret McEntegart

Abstract

Background The objective of the GNOCCI (Glasgow Natural History Study of Covered Stent Coronary Interventions) Study was to report the incidence and outcomes of coronary artery perforations over an 18-year period at a single, high-volume percutaneous coronary intervention center. We considered both the temporal trends and long-term outcomes of covered stent deployment. Methods and Results We evaluated procedural and long-term clinical outcomes following coronary perforation in a cohort of 43,343 consecutive percutaneous coronary intervention procedures. Procedural major adverse cardiac events were defined as a composite of death, myocardial infarction, stroke, target vessel revascularization, or cardiac surgery within 24 hours. A total of 161 (0.37%) procedures were complicated by coronary perforation of which 57 (35%) were Ellis grade III. Incidence increased with time over the study period (r=0.73; P<0.001). Perforation severity was linearly associated with procedural mortality (median 2.9-year follow-up): Ellis I (0%), Ellis II (1.7%), Ellis III/IIIB (21%), P<0.001. Procedural major adverse cardiac events occurred in 47% of patients with Ellis III/IIIB versus 13.5% of those with Ellis I/II perforations (odds ratio, 5.8; 95% CI, 2.7-12.5; P<0.001). Covered stents were associated with an increased risk of stent thrombosis at 2.9-year follow-up (Academic Research Consortium definite or probable; 9.1% versus 0.9%; risk ratio, 10.5; 95% CI, 1.1-97; P=0.04). Conclusions The incidence of coronary perforation increased between 2001 and 2019. Severe perforation was associated with higher procedural major adverse cardiac events and was an independent predictor of long-term mortality. Although covered stents are a potentially lifesaving treatment, the generation of devices used during the study period was limited by their efficacy and high risk of stent thrombosis. Registration Information Clinicaltrials.gov. Identifier: NCT03862352.

Keywords: coronary artery perforation; coronary stent occlusion; covered coronary stent; outcomes; stent thrombosis.

Figures

Figure 1. Ellis classification of coronary perforations.
Figure 1. Ellis classification of coronary perforations.
Figure 2. Temporal trend shows increasing incidence…
Figure 2. Temporal trend shows increasing incidence of coronary perforation incidence (A) and etiology of coronary perforation varies according to severity (B).
Spearman’s rho demonstrates correlation of incidence with time.
Figure 3. Perforation severity predicts long‐term outcomes.
Figure 3. Perforation severity predicts long‐term outcomes.
COX regression all‐cause mortality for Ellis I/II and Ellis III/IIIb coronary perforations. Survival curves and hazard ratio from Cox regression analysis for all‐cause mortality including adjustment for age, sex, indication for angiography, type of arterial access, presence of diabetes, and chronic kidney disease. HR indicates hazard ratio.

References

    1. Gruberg L, Pinnow E, Flood R, Bonnet Y, Tebeica M, Waksman R, Satler LF, Pichard AD, Kent KM, Leon MB, et al. Incidence, management, and outcome of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol. 2000;86(680–682):A8. doi: 10.1016/s0002-9149(00)01053-5
    1. Stathopoulos I, Kossidas K, Panagopoulos G, Garratt K. Cardiac tamponade complicating coronary perforation during angioplasty: short‐term outcomes and long‐term survival. J Invasive Cardiol. 2013;25:486–491.
    1. Ellis SG, Ajluni S, Arnold AZ, Popma JJ, Bittl JA, Eigler NL, Cowley MJ, Raymond RE, Safian RD, Whitlow PL. Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation. 1994;90:2725–2730. doi: 10.1161/01.CIR.90.6.2725
    1. Kinnaird T, Kwok Chun S, Kontopantelis E, Ossei‐Gerning N, Ludman P, deBelder M, Anderson R, Incidence MMA. Determinants, and outcomes of coronary perforation during percutaneous coronary intervention in the United Kingdom. Circ Cardiovasc Interv. . 2016;9(8):e003449. Between 2006 and 2013. doi: 10.1161/CIRCINTERVENTIONS.115.003449
    1. Shimony A, Zahger D, Van Straten M, Shalev A, Gilutz H, Ilia R, Cafri C. Incidence, risk factors, management and outcomes of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol. 2009;104:1674–1677. doi: 10.1016/j.amjcard.2009.07.048
    1. Patel VG, Brayton KM, Tamayo A, Mogabgab O, Michael TT, Lo N, Alomar M, Shorrock D, Cipher D, Abdullah S, et al. Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta‐analysis of 18,061 patients from 65 studies. JACC Cardiovasc Interv. 2013;6:128–136. doi: 10.1016/j.jcin.2012.10.011
    1. El Sabbagh A, Patel VG, Jeroudi OM, Michael TT, Alomar ME, Mogabgab O, Fuh E, Roesle M, Rangan BV, Abdullah S, et al. Angiographic success and procedural complications in patients undergoing retrograde percutaneous coronary chronic total occlusion interventions: a weighted meta‐analysis of 3,482 patients from 26 studies. Int J Cardiol. 2014;174:243–248. doi: 10.1016/j.ijcard.2014.04.004
    1. Prasad A, Rihal CS, Lennon RJ, Wiste HJ, Singh M, Holmes DR. Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25‐year experience from the Mayo Clinic. J Am Coll Cardiol. 2007;49:1611–1618. doi: 10.1016/j.jacc.2006.12.040
    1. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:e574–651. doi: 10.1161/CIR.0b013e31823ba622
    1. Javaid A, Buch AN, Satler LF, Kent KM, Suddath WO, Lindsay J, Pichard AD, Waksman R. Management and outcomes of coronary artery perforation during percutaneous coronary intervention. J Am Coll Cardiol. 2006;98:911–914. doi: 10.1016/j.amjcard.2006.04.032
    1. Stone GW, Goldberg S, O’Shaughnessy C, Midei M, Siegel RM, Cristea E, Dangas G, Lansky AJ, Mehran R. 5‐Year follow‐up of polytetrafluoroethylene‐covered stents compared with bare‐metal stents in aortocoronary saphenous vein grafts: the randomized barricade (barrier approach to restenosis: restrict intima to curtail adverse events) trial. JACC Cardiovasc Interv. 2011;4:300–309. doi: 10.1016/j.jcin.2010.11.013
    1. World Health Organization, International Diabetes Federation . Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. 2006. Available at . Accessed October 14, 2019
    1. World Health Organisation . Hypertension. Available at Accessed October 14, 2019
    1. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WL. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 1988;78:486–502. doi: 10.1161/01.CIR.78.2.486
    1. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Chuang YC, Ditrano CJ, Leon MB. Patterns of calcification in coronary artery disease. Circulation. 1995;91:1959–1965. doi: 10.1161/01.CIR.91.7.1959
    1. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, et al. Standardized bleeding definitions for cardiovascular clinical trials. Circulation. 2011;123:2736–2747. doi: 10.1161/CIRCULATIONAHA.110.009449
    1. Adler Y, Charron P, Imazio M, Badano L, Barón‐Esquivias G, Bogaert J, Brucato A, Gueret P, Klingel K, Lionis C, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseasesThe Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio‐Thoracic Surgery (EACTS). Eur Heart J. 2015;36:2921–2964. doi: 10.1093/eurheartj/ehv318
    1. Kwok CS, Achenbach S, Curzen N, Fischman DL, Savage M, Bagur R, Kontopantelis E, Martin GP, Steg PG, Mamas MA. Relation of frailty to outcomes in percutaneous coronary intervention. Cardiovasc Revasc Med. 2020;21:811–818. doi: 10.1016/j.carrev.2019.11.009
    1. Singh M, Lennon RJ, Holmes DR, Bell MR, Rihal CS. Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention. J Am Coll Cardiol. 2002;40:387–393. doi: 10.1016/S0735-1097(02)01980-0
    1. Shimony A, Joseph L, Mottillo S, Eisenberg MJ. Coronary artery perforation during percutaneous coronary intervention: a systematic review and meta‐analysis. Can J Cardiol. 2011;27:843–850. doi: 10.1016/j.cjca.2011.04.014
    1. Azzalini L, Poletti E, Ayoub M, Ojeda S, Zivelonghi C, La Manna A, Bellini B, Lostalo A, Luque A, Venuti G, et al. Coronary artery perforation during chronic total occlusion percutaneous coronary intervention: epidemiology, mechanisms, management, and outcomes. EuroIntervention. 2019;15:e804–e811. doi: 10.4244/EIJ-D-19-00282
    1. Ford TJ, Khan A, Docherty KF, Jackson A, Morrow A, Sidik N, Rocchiccioli P, Good R, Eteiba H, Watkins S, et al. Sex differences in procedural and clinical outcomes following rotational atherectomy. Catheter Cardiovasc Interv. 2020;95:232–241. doi: 10.1002/ccd.28373
    1. Javaid A, Buch AN, Satler LF, Kent KM, Suddath WO, Lindsay J, Pichard AD, Waksman R. Management and outcomes of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol. 2006;98:911–914. doi: 10.1016/j.amjcard.2006.04.032
    1. Lemmert ME, van Bommel RJ, Diletti R, Wilschut JM, de Jaegere PP, Zijlstra F, Daemen J, Van Mieghem NM. Van Mieghem NM. Clinical Characteristics and Management of Coronary Artery Perforations: A Single‐Center 11‐Year Experience and Practical Overview. J Am Heart Assoc. 2017;6:e007049. 10.1161/JAHA.117.007049
    1. Al‐Lamee R, Ielasi A, Latib A, Godino C, Ferraro M, Mussardo M, Arioli F, Carlino M, Montorfano M, Chieffo A, et al. Incidence, predictors, management, immediate and long‐term outcomes following grade III coronary perforation. JACC Cardiovasc Interv. 2011;4:87–95. doi: 10.1016/j.jcin.2010.08.026
    1. Kinnaird T, Anderson R, Ossei‐Gerning N, Cockburn J, Sirker A, Ludman P, de Belder M, Johnson TW, Copt S, Zaman A, et al. Coronary perforation complicating percutaneous coronary intervention in patients with a history of coronary artery bypass surgery: an analysis of 309 perforation cases from the British cardiovascular intervention society database. Circ Cardiovasc Interv. 2017;10:e005581. 10.1161/CIRCINTERVENTIONS.117.005581
    1. Hernández‐Enríquez M, Lairez O, Campelo‐Parada F, Lhermusier T, Bouisset F, Roncalli J, Elbaz M, Carrié D, Boudou N. Outcomes after use of covered stents to treat coronary artery perforations. Comparison of old and new‐generation covered stents. J Interv Cardiol. 2018;31:617–623. doi: 10.1111/joic.12525

Source: PubMed

3
구독하다